Skip to content

Stryker SYK Short-Term Investments

Short-Term Investments at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$336M+10.9%
Axogen logo
AxogenAXGN
$16.84M+70.3%
Vericel logo
VericelVCEL
$36.05M-8.5%
IAR
Integra LifeSciencesIART
$59.67M+67.2%
Intuitive Surgical logo
Intuitive SurgicalISRG
$2.46B+27.7%
Globus Medical logo
Globus MedicalGMED
$68.9M

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$132.87B-13.2%
Enterprise value$144.38B-13.8%
P/E39.8×-12.6×
P/S5.3×-1.2×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp
FCF margin18.1%+2.7pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:OtherShortTermInvestments.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's short-term investments?
Stryker (SYK) reported short-term investments of $0 in Q1 2026.
What is the long-term trend for Stryker's short-term investments?
Over 5 years (2020 to 2025), Stryker's short-term investments has grown at a -100.0% compound annual growth rate (CAGR), from $81M to $0.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.